» Articles » PMID: 29551266

Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis

Abstract

Protein degradation plays important roles in biological processes and is tightly regulated. Further, targeted proteolysis is an emerging research tool and therapeutic strategy. However, proteome-wide technologies to investigate the causes and consequences of protein degradation in biological systems are lacking. We developed "multiplexed proteome dynamics profiling" (mPDP), a mass-spectrometry-based approach combining dynamic-SILAC labeling with isobaric mass tagging for multiplexed analysis of protein degradation and synthesis. In three proof-of-concept studies, we uncover different responses induced by the bromodomain inhibitor JQ1 versus a JQ1 proteolysis targeting chimera; we elucidate distinct modes of action of estrogen receptor modulators; and we comprehensively classify HSP90 clients based on their requirement for HSP90 constitutively or during synthesis, demonstrating that constitutive HSP90 clients have lower thermal stability than non-clients, have higher affinity for the chaperone, vary between cell types, and change upon external stimuli. These findings highlight the potential of mPDP to identify dynamically controlled degradation mechanisms in cellular systems.

Citing Articles

Single-Cell Sequencing and Transcriptome Analysis Explored Changes in Midnolin-Related Immune Microenvironment and Constructed Combined Prognostic Model for Pancreatic Cancer.

Guan X, Xu L, Liu J, Fei H, Wang C J Inflamm Res. 2025; 18:2975-2990.

PMID: 40026303 PMC: 11872096. DOI: 10.2147/JIR.S503326.


Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays.

Van Vranken J, Li J, Mintseris J, Wei T, Sniezek C, Gadzuk-Shea M Elife. 2024; 13.

PMID: 39526730 PMC: 11554310. DOI: 10.7554/eLife.95595.


Advances in the Clinical Application of High-throughput Proteomics.

Cui M, Deng F, Disis M, Cheng C, Zhang L Explor Res Hypothesis Med. 2024; 9(3):209-220.

PMID: 39148720 PMC: 11326426. DOI: 10.14218/erhm.2024.00006.


Global protein turnover quantification in Escherichia coli reveals cytoplasmic recycling under nitrogen limitation.

Gupta M, Johnson A, Cruz E, Costa E, Guest R, Li S Nat Commun. 2024; 15(1):5890.

PMID: 39003262 PMC: 11246515. DOI: 10.1038/s41467-024-49920-8.


[Recent advances in protein precipitation-based methods for drug-target screening].

Liu T, Qin W, Yang H Se Pu. 2024; 42(7):613-622.

PMID: 38966970 PMC: 11224935. DOI: 10.3724/SP.J.1123.2023.11019.


References
1.
Arlander S, Felts S, Wagner J, Stensgard B, Toft D, Karnitz L . Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones. J Biol Chem. 2005; 281(5):2989-98. DOI: 10.1074/jbc.M508687200. View

2.
Wilhelm M, Schlegl J, Hahne H, Gholami A, Lieberenz M, Savitski M . Mass-spectrometry-based draft of the human proteome. Nature. 2014; 509(7502):582-7. DOI: 10.1038/nature13319. View

3.
Fliss A, Benzeno S, Rao J, Caplan A . Control of estrogen receptor ligand binding by Hsp90. J Steroid Biochem Mol Biol. 2000; 72(5):223-30. DOI: 10.1016/s0960-0760(00)00037-6. View

4.
Fierro-Monti I, Echeverria P, Racle J, Hernandez C, Picard D, Quadroni M . Dynamic impacts of the inhibition of the molecular chaperone Hsp90 on the T-cell proteome have implications for anti-cancer therapy. PLoS One. 2013; 8(11):e80425. PMC: 3842317. DOI: 10.1371/journal.pone.0080425. View

5.
Boersema P, Raijmakers R, Lemeer S, Mohammed S, Heck A . Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc. 2009; 4(4):484-94. DOI: 10.1038/nprot.2009.21. View